Cagrilintide
CagrilintideCreate a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for Cagrilintide.
Acts as an amylin receptor agonist to enhance satiety
Reduces appetite and caloric intake in clinical studies
Slows gastric emptying, promoting earlier fullness
Associated with body weight reduction in trials
Shows additive weight-loss effects with GLP-1 agonists
May improve glycaemic control when combined with GLP-1 therapy
Favors reduction in fat mass versus lean mass in studies
Once-weekly, long-acting formulation may support adherence
This peptide's combination-safety and interaction data below always stays visible, regardless of membership.
Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.
0 Published Studies
Scientific literature related to Cagrilintide and its potential applications.
Research Intelligence
No published research analyses are available for this peptide yet.